BG103432A - Derivatives of 1,4-diazabicyclo[2.2.2]oct-2-ylmethylbenzoate, method for their preparation and application in therapy - Google Patents
Derivatives of 1,4-diazabicyclo[2.2.2]oct-2-ylmethylbenzoate, method for their preparation and application in therapyInfo
- Publication number
- BG103432A BG103432A BG103432A BG10343299A BG103432A BG 103432 A BG103432 A BG 103432A BG 103432 A BG103432 A BG 103432A BG 10343299 A BG10343299 A BG 10343299A BG 103432 A BG103432 A BG 103432A
- Authority
- BG
- Bulgaria
- Prior art keywords
- ylmethylbenzoate
- diazabicyclo
- oct
- therapy
- derivatives
- Prior art date
Links
- NAIHEECEPHODMQ-UHFFFAOYSA-N 1,4-diazabicyclo[2.2.2]octan-3-ylmethyl benzoate Chemical class C1N(CC2)CCN2C1COC(=O)C1=CC=CC=C1 NAIHEECEPHODMQ-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000387 serotonin 5-HT4 receptor agonist Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9614847A FR2756563B1 (fr) | 1996-12-04 | 1996-12-04 | Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique |
| PCT/FR1997/002174 WO1998024790A1 (fr) | 1996-12-04 | 1997-12-02 | Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-ylmethyle, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG103432A true BG103432A (en) | 2000-06-30 |
Family
ID=9498306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103432A BG103432A (en) | 1996-12-04 | 1999-05-26 | Derivatives of 1,4-diazabicyclo[2.2.2]oct-2-ylmethylbenzoate, method for their preparation and application in therapy |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6057321A (xx) |
| EP (1) | EP0942910A1 (xx) |
| JP (1) | JP2001504855A (xx) |
| KR (1) | KR20000069283A (xx) |
| CN (1) | CN1239962A (xx) |
| AU (1) | AU7624598A (xx) |
| BG (1) | BG103432A (xx) |
| BR (1) | BR9714215A (xx) |
| CA (1) | CA2271072A1 (xx) |
| CZ (1) | CZ193799A3 (xx) |
| EE (1) | EE9900218A (xx) |
| FR (1) | FR2756563B1 (xx) |
| HU (1) | HUP9904206A3 (xx) |
| IL (1) | IL129927A0 (xx) |
| NO (1) | NO992676L (xx) |
| NZ (1) | NZ336044A (xx) |
| SK (1) | SK74199A3 (xx) |
| TR (1) | TR199901068T2 (xx) |
| WO (1) | WO1998024790A1 (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL122484A0 (en) | 1995-06-07 | 1998-06-15 | Noven Pharma | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| EP1611197B1 (en) * | 2003-04-08 | 2012-03-21 | Basf Se | Light stabilising polymer dispersants in pigment dispersions |
| US7880683B2 (en) * | 2004-08-18 | 2011-02-01 | Ruckus Wireless, Inc. | Antennas with polarization diversity |
| JP5278312B2 (ja) | 2007-04-16 | 2013-09-04 | ダイキン工業株式会社 | 含フッ素エラストマー組成物およびそれからなるシール材 |
| US20100204438A1 (en) * | 2007-09-03 | 2010-08-12 | Basf Se | Method for producing teda derivatives |
| CN103265677B (zh) * | 2008-05-30 | 2016-06-08 | 东曹株式会社 | 羟基烷基三亚乙基二胺类化合物的制造方法及使用其的聚氨酯树脂制造用催化剂组合物 |
| US20110077376A1 (en) * | 2008-05-30 | 2011-03-31 | Katsumi Tokumoto | Process for producing hydroxyalkyltriethylenediamine, and catalyst composition for the production of polyurethane resin using it |
| CN101671336B (zh) * | 2009-09-23 | 2013-11-13 | 辽宁利锋科技开发有限公司 | 芳杂环并嘧啶衍生物和类似物及其制备方法和用途 |
| JP5504835B2 (ja) * | 2009-11-13 | 2014-05-28 | 東ソー株式会社 | ヒドロキシアルキルピペラジン類及び／又はヒドロキシメチルトリエチレンジアミン類の製造方法 |
| JP5549847B2 (ja) * | 2009-11-16 | 2014-07-16 | 東ソー株式会社 | Ｎ−（２−アルコキシメチル）トリエチレンジアミン類の製造法 |
| JP5707912B2 (ja) * | 2010-12-08 | 2015-04-30 | 東ソー株式会社 | Ｎ−（ジヒドロキシアルキル）ジエチレントリアミン類の組成物、及びそれを用いた２−ヒドロキシ（アルキル）トリエチレンジアミン類の製造方 |
| JP6393959B2 (ja) | 2012-05-31 | 2018-09-26 | 東ソー株式会社 | ポリウレタン樹脂製造用触媒組成物及びそれを用いたポリウレタン樹脂の製造方法 |
| JP6252152B2 (ja) * | 2013-12-11 | 2017-12-27 | 東ソー株式会社 | 二環式アミン化合物の製造方法 |
| KR20220055152A (ko) | 2020-10-26 | 2022-05-03 | 인하대학교 산학협력단 | 급성 융모양막염 진단용 조성물 및 이를 이용한 급성 융모양막염 진단방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772459A (en) * | 1986-09-09 | 1988-09-20 | Erbamont, Inc. | Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein |
| TW282460B (xx) * | 1993-12-28 | 1996-08-01 | Yamanouchi Pharma Co Ltd | |
| FR2735475B1 (fr) * | 1995-06-13 | 1997-07-11 | Synthelabo | Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique |
-
1996
- 1996-12-04 FR FR9614847A patent/FR2756563B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-02 EE EEP199900218A patent/EE9900218A/xx unknown
- 1997-12-02 JP JP52527298A patent/JP2001504855A/ja active Pending
- 1997-12-02 IL IL12992797A patent/IL129927A0/xx unknown
- 1997-12-02 TR TR1999/01068T patent/TR199901068T2/xx unknown
- 1997-12-02 EP EP97948976A patent/EP0942910A1/fr not_active Withdrawn
- 1997-12-02 HU HU9904206A patent/HUP9904206A3/hu unknown
- 1997-12-02 US US09/319,413 patent/US6057321A/en not_active Expired - Fee Related
- 1997-12-02 CZ CZ991937A patent/CZ193799A3/cs unknown
- 1997-12-02 WO PCT/FR1997/002174 patent/WO1998024790A1/fr not_active Ceased
- 1997-12-02 BR BR9714215-8A patent/BR9714215A/pt not_active Application Discontinuation
- 1997-12-02 NZ NZ336044A patent/NZ336044A/xx unknown
- 1997-12-02 AU AU76245/98A patent/AU7624598A/en not_active Abandoned
- 1997-12-02 SK SK741-99A patent/SK74199A3/sk unknown
- 1997-12-02 CN CN97180353A patent/CN1239962A/zh active Pending
- 1997-12-02 KR KR1019997004915A patent/KR20000069283A/ko not_active Withdrawn
- 1997-12-02 CA CA002271072A patent/CA2271072A1/fr not_active Abandoned
-
1999
- 1999-05-26 BG BG103432A patent/BG103432A/xx unknown
- 1999-06-02 NO NO992676A patent/NO992676L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2756563A1 (fr) | 1998-06-05 |
| CZ193799A3 (cs) | 1999-09-15 |
| EP0942910A1 (fr) | 1999-09-22 |
| BR9714215A (pt) | 2000-04-18 |
| EE9900218A (et) | 1999-12-15 |
| NZ336044A (en) | 2000-03-27 |
| US6057321A (en) | 2000-05-02 |
| NO992676L (no) | 1999-07-29 |
| SK74199A3 (en) | 2000-02-14 |
| JP2001504855A (ja) | 2001-04-10 |
| AU7624598A (en) | 1998-06-29 |
| IL129927A0 (en) | 2000-02-29 |
| HUP9904206A3 (en) | 2000-07-28 |
| WO1998024790A1 (fr) | 1998-06-11 |
| FR2756563B1 (fr) | 1998-12-24 |
| KR20000069283A (ko) | 2000-11-25 |
| HUP9904206A2 (hu) | 2000-06-28 |
| TR199901068T2 (xx) | 1999-07-21 |
| CN1239962A (zh) | 1999-12-29 |
| NO992676D0 (no) | 1999-06-02 |
| CA2271072A1 (fr) | 1998-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG103432A (en) | Derivatives of 1,4-diazabicyclo[2.2.2]oct-2-ylmethylbenzoate, method for their preparation and application in therapy | |
| TW336939B (en) | Lipopeptide derivatives, a process for their preparation and their use | |
| MD1616F2 (en) | Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment | |
| MD1632F2 (en) | Bicyclic compounds, method of inhibiting the tyrosine kinases receptors as epidermal growth factor, pharmaceutical composition, methods of preventing blastocyte implantation and treatment of mammals | |
| JPS6445385A (en) | Pyrazolopyridine compound and production thereof | |
| PL316658A1 (en) | Novel application of serotonin antagonists | |
| EA200100058A1 (ru) | 4-бензилпиперидиналкилсульфоксидные гетероциклические соединения и их применение в качестве подтип-избирательных антагонистов nmda-рецепторов | |
| MX9603050A (es) | Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas. | |
| RU94036004A (ru) | Промежуточные соединения для получения ароматических аминоспиртовых производных | |
| DK0640592T3 (da) | N-acylerede tricycliske azaheteroringe anvendelige som vasopressin-antagonister | |
| ES529811A0 (es) | Procedimiento para preparar derivados de n-fenil-benzamida | |
| EA199700111A1 (ru) | Трициклические бензазепиновые антагонисты вазопрессина | |
| IL80108A (en) | Process for preparing 1,4-diisopropyl-2,5-diketopiperazines | |
| PL316870A1 (en) | Derivatives of 5-heterocyclo 1,5-benzodiazepine | |
| DE69509888D1 (de) | IMIDAZO[1,2-a]INDENO [1,2-e] PYRAZINONE ANTAGONISTEN DER AMPA UND NMDA REZEPTOREN | |
| GR3035363T3 (en) | Bridged cyclopentadienyl-magnesium compounds, their preparation and use in preparing metallocenes. | |
| BG103810A (en) | Derivatives of 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-on as ligands of 5-ht4 receptors | |
| EP0251574A3 (en) | Antifungal derivatives of n-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same | |
| MX9603199A (es) | Antagonistas de receptores a endotelina. | |
| MX9801133A (es) | Agente endoparasiticida a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su produccion. | |
| BG102238A (en) | New imidazoline-2,4-dions of anticonvulsion effect containing, in the first place, orthosubstituted ar(alk)yl radical, and method for their preparation | |
| BG102779A (en) | Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo[3.2.1] octane, method for their preparation and application in therapy | |
| JPS5634674A (en) | Isoxazolin-3-one derivative | |
| HUP9701542A2 (hu) | A prolaktinszintre semleges hatású 8,9-dehidroösztron ösztrogénként való alkalmazása | |
| KE3478A (en) | N-substituted-6-oxamorphinans |